Alnylam Pharmaceuticals (ALNY) PT Raised to $206 at Leerink Partners
Tweet
Share
E-mailGet Alerts ALNY Hot Sheet
Price: $228.65 --0%
Rating Summary:
29 Buy, 12 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 14 | New: 19
Rating Summary:
29 Buy, 12 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 14 | New: 19
Join SI Premium – FREE
Leerink Partners analyst Mani Foroohar raised the price target on Alnylam Pharmaceuticals (NASDAQ: ALNY) to $206.00 (from $200.00) while maintaining a Market Perform rating.
You May Also Be Interested In
- Deutsche Bank Downgrades Workday (WDAY) to Hold
- Aebi Schmidt Holding AG (AEBI) PT Raised to $17 at DA Davidson
- High Liner Foods Inc. (HLF:CN) (HLNFF) PT Raised to Cdn$17.50 at BMO Capital
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
